Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Translational Behavioral Medicine
Published in: Translational Behavioral Medicine 3/2011

01-09-2011

Translation of the diabetes prevention program into a community mental health organization for individuals with severe mental illness: a case study

Authors: Kristin L Schneider, PhD, J Cherry Sullivan, PhD, Sherry L Pagoto, PhD1

Published in: Translational Behavioral Medicine | Issue 3/2011

Login to get access

ABSTRACT

Individuals with severe mental illness (SMI) have significant health disparities. Wellness services embedded in community mental health organizations could lessen these disparities. This case study illustrates the integration of the Diabetes Prevention Program (DPP) lifestyle intervention into a community mental health organization. The Diffusion of Innovations Theory was used as a model for integration, which included a collaboration between researchers and the organization and qualitative work, culminating in a small pilot of the DPP led by peer specialists to test the feasibility of the DPP in this setting. Fourteen individuals with SMI participated in the 19-week intervention. Three dropped out, but the remaining 11 demonstrated 92% attendance. Weight loss was minimal, but the participants reported benefit and showed continued interest in the intervention. The use of a peer-led DPP in a community mental health organization is feasible and warrants further investigation to demonstrate efficacy.
Literature
1.
Hennekens, C. H. (2007). Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. The Journal of Clinical Psychiatry, 68(Suppl 4), 4–7.PubMed
2.
DE Hert, M., Schreurs, V., Vancampfort, D., & VAN Winkel, R. (2009). Metabolic syndrome in people with schizophrenia: a review. World Psychiatry, 8(1), 15–22.
3.
Douglas, I. J., & Smeeth, L. (2008). Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ, 337, a1227.PubMedCrossRef
4.
Newcomer, J. W. (2005). Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs, 19(Suppl 1), 1–93.PubMed
5.
Pagoto S, Schneider K, Appelhans B, Curtin C, Hadjuk A. Psychological comorbidities of obesity. In: Pagoto S, editor. Psychological comorbidities of physical illness: a behavioral medicine perspective. New York: Springer; (in press).
6.
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596–601.CrossRef
7.
Brown, S., Birtwistle, J., Roe, L., & Thompson, C. (1999). The unhealthy lifestyle of people with schizophrenia. Psychological Medicine, 29(3), 697–701.PubMedCrossRef
8.
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121.PubMedCrossRef
9.
Dixon, L. B., Dickerson, F., Bellack, A. S., et al. (2010). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 48–70.PubMedCrossRef
10.
Alvarez-Jimenez, M., Hetrick, S. E., Gonzalez-Blanch, C., Gleeson, J. F., & McGorry, P. D. (2008). Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. The British Journal of Psychiatry, 193(2), 101–107.PubMedCrossRef
11.
Gabriele, J. M., Dubbert, P. M., & Reeves, R. R. (2009). Efficacy of behavioural interventions in managing atypical antipsychotic weight gain. Obesity Reviews, 10(4), 442–455.PubMedCrossRef
12.
Radke, A. Q., Parks, J., & Ruter, T. J. (2010). A call for improved prevention and reduction of obesity among persons with serious mental illness. Psychiatric Services, 61(6), 617–619.PubMedCrossRef
13.
USDHHS. (2010). The 10 by 10 campaign: a national wellness action plan to improve life expectancy by 10 years in 10 years for people with mental illness. A report of the 2007 National Wellness Summit for people with mental illness. Washington, D.C.: International Med Publishing.
14.
Rogers, E. M. (2003). Diffusion of innovations (5th ed.). New York: Free Press.
15.
Ryan, T., Webb, L., & Meier, P. S. (2006). A systems approach to care pathways into in-patient alcohol detoxification: outcomes from a retrospective study. Drug and Alcohol Dependence, 85(1), 28–34.PubMedCrossRef
16.
DPP Research Group. (2004). Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obesity Research, 12(9), 1426–1434.CrossRef
17.
Weber, M., & Wyne, K. (2006). A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83(1), 95–101.PubMedCrossRef
18.
Mau, M. K., Keawe'aimoku Kaholokula, J., West, M. R., et al. (2010). Translating diabetes prevention into native Hawaiian and Pacific Islander communities the PILI 'Ohana Pilot project. Progress in community health partnerships research, education, and action, 4(1), 7–16.PubMedCrossRef
19.
Parikh, P., Simon, E. P., Fei, K., Looker, H., Goytia, C., & Horowitz, C. R. (2010). Results of a Pilot Diabetes Prevention Intervention in East Harlem, New York City: Project HEED. American Journal of Public Health, 100(Suppl 1), S232–S239.PubMedCrossRef
20.
Pagoto, S. L., Kantor, L., Bodenlos, J. S., Gitkind, M., & Ma, Y. (2008). Translating the Diabetes Prevention Program into a hospital-based weight loss program. Health Psychology, 27(1), S91–S98.PubMedCrossRef
21.
Schneider, K. L., Bodenlos, J. S., Ma, Y., et al. (2008). Design and methods for a randomized clinical trial for co-morbid obesity and major depressive disorder. BMC Psychiatry, 8(1), 77.PubMedCrossRef
22.
Pagoto, S. L., Bodenlos, J. S., Schneider, K. L., Olendzki, B., Spates, R. C., & Ma, Y. (2008). Initial investigation of behavioral activation therapy for co-morbid major depressive disorder and obesity. Psychotherapy Theory, Research, Practice, Training., 45(3), 410–415.CrossRef
23.
Backer, T. E. (2000). Finding the balance: program fidelity and adaptation in substance abuse prevention. Washington, D.C.: Center for Substance Abuse Prevention.
24.
Van Citters, A. D., Pratt, S. I., Jue, K., et al. (2010). A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness. Community Mental Health Journal, 46, 540–552.PubMedCrossRef
25.
Pagoto, S. L., Bodenlos, J. S., Kantor, L., Gitkind, M., Curtin, C., & Ma, Y. (2007). Association of major depression and binge eating disorder with weight loss in a clinical setting. Obesity, 15(11), 2557–2559.PubMedCrossRef
26.
Pagoto, S. L., Curtin, C., Bandini, L. G., et al. (2010). Weight loss following a clinic-based weight loss program among adults with attention deficit/hyperactivity. Disorder symptoms Eat Weight Disord, 15, e166–172.
Metadata
Title
Translation of the diabetes prevention program into a community mental health organization for individuals with severe mental illness: a case study
Authors
Kristin L Schneider, PhD
J Cherry Sullivan, PhD
Sherry L Pagoto, PhD1
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Translational Behavioral Medicine / Issue 3/2011
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-011-0053-z

Other articles of this Issue 3/2011

Translational Behavioral Medicine 3/2011 Go to the issue

OriginalPaper

News from NIH: obesity and diabetes

OriginalPaper

A pilot study to expand the school breakfast program in one middle school

OriginalPaper

Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!

ReviewPaper

Youth advocacy for obesity prevention: the next wave of social change for health

OriginalPaper

The Society of Behavioral Medicine (SBM) and public policy advocacy: a call to action

ReviewPaper

A systematic review of the translational research on the Diabetes Prevention Program